Work

Abstract 3136: EOS-215, a first-in-class TREM2 antagonist, designed to reprogram the tumor microenvironment and overcome resistance

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-3136

Authors: Thibaut Janss, Romain Pirson, Virginie Rabolli, Iain Welsby, Clotilde Hoyos, Quentin Dubray, Laura Saerens, Jean-Philippe Deglasse, David Carbonez, Lennart Raman, Francesco Strozzi, Julie Chesne, Joao Matos Marchante, Reece Marillier, Yvonne McGrath, Catherine Hoofd

Language: English

Topic: Immune cells in cancer

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409631426

Cites:

Cited by: 6

Related to: 10